Advanced Medical Isotope Corporation (OTCMKTS:RDGL) Short Interest Update

Advanced Medical Isotope Corporation (OTCMKTS:RDGL) was the target of a large decline in short interest in July. As of July 15th, there was short interest totaling 66,933 shares, a decline of 52.9% from the June 30th total of 142,100 shares. Based on an average trading volume of 8,132,292 shares, the short-interest ratio is currently 0.0 days. Approximately 0.0% of the shares of the stock are short sold.

Advanced Medical Isotope Trading Up 1.5%

OTCMKTS:RDGL traded up $0.00 during mid-day trading on Thursday, hitting $0.06. The company’s stock had a trading volume of 250,519 shares, compared to its average volume of 1,225,213. The company has a market capitalization of $29.24 million, a price-to-earnings ratio of -5.92 and a beta of -0.75. Advanced Medical Isotope has a fifty-two week low of $0.04 and a fifty-two week high of $0.14. The stock has a fifty day moving average of $0.06 and a 200-day moving average of $0.07.

About Advanced Medical Isotope

Vivos Inc, a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc in December 2017. Vivos Inc was incorporated in 1994 and is headquartered in Richland, Washington.